Drugs / HPDCs-T
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01935635 | Jan 2015 → Dec 2019 | chronic hepatitis B virus infection | Third Affiliated Hospital, Sun Yat-Sen University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HPDCs-T | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01935635 ↗ |
| Known as | HPDCT | “autologous HBV vaccine-pulsed DCs and their induced T cells (HPDCT) in CHB patients.” PMID 39815989 ↗ Feb 2025 |
| Route | Intravenous | “IV (in the vein)” NCT01935635 ↗ |